Janusz A. Jankowski, Nick A. Wright, Stephen J

Slides:



Advertisements
Similar presentations
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Advertisements

Gastrointestinal pathology esophagus and stomach lecture 2
Endomicroscopy is born—do we still need the pathologist?
Rapid Development of Salivary Gland Carcinomas upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter  Ana R. Raimondi, Lynn Vitale-Cross,
Barrett's esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer 
Controversies in Barrett Esophagus
Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region  Tsung-Teh Wu, Toshiaki Watanabe, Richard.
The Esophageal Squamous Epithelial Cell—Still a Reasonable Candidate for the Barrett’s Esophagus Cell of Origin?  David H. Wang, MD, PhD  Cellular and.
Turning Skyscrapers into Town Houses: Insights into Barrett's Esophagus Pathobiology 2017;84: DOI: / Fig. 1.a BE develops via conversion.
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Mouse Models of Colon Cancer
GI Pathology Lab Dr Heyam.
Rodica Ouatu–Lascar, Rebecca C. Fitzgerald, George Triadafilopoulos 
Alvin Y. Liu, Martine P. Roudier, Lawrence D. True 
(A) Region of esophagus demonstrating Barrett esophagus: The normal squamous epithelium (left margin of figure) is replaced by specialized columnar epithelium.
Thomas Kirchner, Thomas Brabletz  The American Journal of Pathology 
Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus  Pramod Bonde, MD, MS, FRCS, Daqing Gao, PhD, Lei.
Volume 144, Issue 4, Pages (April 2013)
Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers  Rebecca A. Betensky, Catherine.
Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett’s Esophagus  Ganapathy A. Prasad,
Mouse Models of Colon Cancer
Carcinogenesis of Helicobacter pylori
Volume 149, Issue 7, Pages (December 2015)
Grounded: Transcriptional Pausing in Naive mESCs
Kulwinder S. Dua, MD, Joseph Merrill, MD  Gastrointestinal Endoscopy 
Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma  Robert A. Soslow, MD, Liang Ying, BS, Nasser.
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Corneal Epithelial Stem Cells: Past, Present, and Future
KRAS, NRAS, PIK3CA Exon 20, and BRAF Genotypes in Synchronous and Metachronous Primary Colorectal Cancers  Katharina Balschun, Jochen Haag, Ann-Kathrin.
Steven H Itzkowitz, Noam Harpaz  Gastroenterology 
Volume 145, Issue 4, Pages (October 2013)
Volume 154, Issue 4, Pages (March 2018)
Volume 138, Issue 5, Pages e2 (May 2010)
Molecular Validation of the Modified Vienna Classification of Colorectal Tumors  Tamotsu Sugai, Wataru Habano, Noriyuki Uesugi, Yu-Fei Jiao, Shin-ichi.
Keratinocyte Stem Cells: a Commentary1
Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model  Pramod Bonde, MD, MS, FRCS, Guoping Sui,
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Volume 128, Issue 4, Pages (April 2005)
Mutually Exclusive Promoter Hypermethylation Patterns of hMLH1 and O6- Methylguanine DNA Methyltransferase in Colorectal Cancer  Edward J. Fox, Dermot.
Volume 122, Issue 3, Pages (March 2002)
A novel biomarker for the detection of esophageal adenocarcinoma
Gastrointestinal Pathology I
Wide-area transepithelial sampling with 3-dimensional cytology: Does it detect more dysplasia or yield more hype?  Marcia Irene Canto, MD, MHS  Gastrointestinal.
Epidermal Differentiation: Transgenic/Knockout Mouse Models Reveal Genes Involved in Stem Cell Fate Decisions and Commitment to Differentiation  Maranke.
Gastric Epithelial Stem Cells
Volume 143, Issue 3, Pages e1 (September 2012)
p63 and Epithelial Metaplasia: A Gutsy Choice
Stem Cell Heterogeneity and Plasticity in Epithelia
Puma: Mauling the Intestinal Crypt
The Morphogenetic Code and Colon Cancer Development
MicroRNA expression profiles of esophageal cancer
Acetic-acid chromoendoscopy for Barrett's esophagus: the “pros”
Roxanne Toivanen, Adithi Mohan, Michael M. Shen  Stem Cell Reports 
The diagnosis of Barrett's esophagus: goblets, goblets, goblets
Inflammation, Atrophy, Gastric Cancer: Connecting the Molecular Dots
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Molecular Mechanisms Regulating Hair Follicle Development
From Cancer Stem Cells to Tumor Maintenance in Melanoma
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
The Gastrointestinal Tumor Microenvironment
Karen Snow-Bailey, Ph.D., 1961–2006
Stressing Out PanIN: NRF2 Pushes over the Edge
Much ado about very little (lamina propria)?
Janusz A. Jankowski, Dawn Provenzale, Paul Moayyedi  Gastroenterology 
F. Henry Ellis, MD, PhD, Xiangjun Xu, MD, PhD, Matthew H
Marcia Irene Canto, MD, MHS  Gastrointestinal Endoscopy 
Controversies in Barrett Esophagus
Kiran H. Lagisetty, David G. Beer, Andrew C. Chang 
Driver pathways and key genes in OSCC
Complete intestinal metaplasia (IM) is characterised by goblet cells stained red or blue by alcian blue (pH 2.5)-periodic acid Schiff stain and by the.
Presentation transcript:

Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus  Janusz A. Jankowski, Nick A. Wright, Stephen J. Meltzer, George Triadafilopoulos, Karl Geboes, Alan G. Casson, David Kerr, Lawrence S. Young  The American Journal of Pathology  Volume 154, Issue 4, Pages 965-973 (April 1999) DOI: 10.1016/S0002-9440(10)65346-1 Copyright © 1999 American Society for Investigative Pathology Terms and Conditions

Figure 1 Photomicrograph of intestinal metaplasia in Barrett's esophagus stained with Alcian blue/periodic acid-Schiff (mucins). Barrett's esophagus is composed of columnar lined mucus-secreting cells and a proportion of the glands will be composed of goblet cells (small arrowhead). Alcian blue diastase periodic acid-Schiff staining indicates the heterogeneity of mucin phenotypes in esophageal cells: blue (basic), red (neutral), and purple (mixed) mucins (large arrowhead). Original magnification, ×250. The American Journal of Pathology 1999 154, 965-973DOI: (10.1016/S0002-9440(10)65346-1) Copyright © 1999 American Society for Investigative Pathology Terms and Conditions

Figure 2 Schematic representation of adaptation during Barrett's mucosa formation. The three compartments of the esophageal epithelium are represented on the diagrams. The bottom of each diagram shows basal compartment containing both stem cells (speckled nucleus) and proliferating cells; the middle, parabasal compartment containing proliferating cells; and the top, superficial compartment containing only mature differentiated cells. The uninflamed mucosa (right) is flat, whereas the inflamed mucosa (left) has invaginations of the basal layer, termed papillae. A: Damage to the esophageal differentiated cells in the superficial and parabasal compartments of the esophagus. B: Damage to a deeper compartment involving the squamous epithelial stem cells in the basal compartment of the papillae. C: Generation of clones with a mucin-secreting lineage resistant to acid/bile. The American Journal of Pathology 1999 154, 965-973DOI: (10.1016/S0002-9440(10)65346-1) Copyright © 1999 American Society for Investigative Pathology Terms and Conditions

Figure 2 Schematic representation of adaptation during Barrett's mucosa formation. The three compartments of the esophageal epithelium are represented on the diagrams. The bottom of each diagram shows basal compartment containing both stem cells (speckled nucleus) and proliferating cells; the middle, parabasal compartment containing proliferating cells; and the top, superficial compartment containing only mature differentiated cells. The uninflamed mucosa (right) is flat, whereas the inflamed mucosa (left) has invaginations of the basal layer, termed papillae. A: Damage to the esophageal differentiated cells in the superficial and parabasal compartments of the esophagus. B: Damage to a deeper compartment involving the squamous epithelial stem cells in the basal compartment of the papillae. C: Generation of clones with a mucin-secreting lineage resistant to acid/bile. The American Journal of Pathology 1999 154, 965-973DOI: (10.1016/S0002-9440(10)65346-1) Copyright © 1999 American Society for Investigative Pathology Terms and Conditions

Figure 2 Schematic representation of adaptation during Barrett's mucosa formation. The three compartments of the esophageal epithelium are represented on the diagrams. The bottom of each diagram shows basal compartment containing both stem cells (speckled nucleus) and proliferating cells; the middle, parabasal compartment containing proliferating cells; and the top, superficial compartment containing only mature differentiated cells. The uninflamed mucosa (right) is flat, whereas the inflamed mucosa (left) has invaginations of the basal layer, termed papillae. A: Damage to the esophageal differentiated cells in the superficial and parabasal compartments of the esophagus. B: Damage to a deeper compartment involving the squamous epithelial stem cells in the basal compartment of the papillae. C: Generation of clones with a mucin-secreting lineage resistant to acid/bile. The American Journal of Pathology 1999 154, 965-973DOI: (10.1016/S0002-9440(10)65346-1) Copyright © 1999 American Society for Investigative Pathology Terms and Conditions

Figure 3 Schematic representation of the key molecular events in Barrett's dysplasia, the metaplasia-dysplasia-adenocarcinoma sequence (MCS). Acid and bile cause acute damage to the esophagus, which is rapidly healed by restitution or cellular replication (stages 1 and 2). In 10% of cases chronic damage to the epithelial stem cells allows rapid clonal replacement by lineages with a growth advantage containing p53 mutations (stage 2). The formation of each type of Barrett's metaplasia is dependent on the stem cell from which it arises as well as the nature of the mucosal microenvironment. Appearance of dysplasia is associated in part with loss of heterozygosity of APC or alterations in the catenins (stage 3). In 1 in 100 cases, aneuploidy and errors in DNA repair represent final pathways which disrupt invasion suppressor genes (stages 4 and 5). The transition from high grade dysplasia to invasive cancer is rapid in all cases. The American Journal of Pathology 1999 154, 965-973DOI: (10.1016/S0002-9440(10)65346-1) Copyright © 1999 American Society for Investigative Pathology Terms and Conditions